Consequently, this real-world study examined the prevalence of PD-L1 expression (CPS ≥1) determined using a Food and Drug Administration–approved kit, MSI-H frequency, and EBV positivity in Japanese patients with advanced GC and GEJ adenocarcinoma. Here, CD274 is linked to gastroesophageal junction adenocarcinoma.